| Characteristics . | Values . |
|---|---|
| Female, n (%) | 65 (56) |
| Age of onset, mean (s.d.), years | 52 (13) |
| Smoker, n (%) | 9 (7.8) |
| Ethnicity, n (%) | |
| Chinese | 112 (97) |
| Indonesian | 2 (2) |
| Malaysian | 1 (1) |
| Subtypes, n (%) | |
| DM | 38 (32.8) |
| CADM | 78 (67.2) |
| PM | 0 (0) |
| ILD, n (%) | 100 (86.2) |
| RP-ILD, n (%) | 47 (40.5) |
| Overall mortality, n/N (%) | 44/116 (37.9) |
| 3 month survival rate, n/N (%) | 83/116 (71.6) |
| 6 month survival rate, n/N (%) | 80/116 (69.0) |
| 12 month survival rate, n/N (%) | 74/116 (63.8) |
| Follow-up duration, mean (s.d.), months | 19.3 (21.6) |
| Characteristics . | Values . |
|---|---|
| Female, n (%) | 65 (56) |
| Age of onset, mean (s.d.), years | 52 (13) |
| Smoker, n (%) | 9 (7.8) |
| Ethnicity, n (%) | |
| Chinese | 112 (97) |
| Indonesian | 2 (2) |
| Malaysian | 1 (1) |
| Subtypes, n (%) | |
| DM | 38 (32.8) |
| CADM | 78 (67.2) |
| PM | 0 (0) |
| ILD, n (%) | 100 (86.2) |
| RP-ILD, n (%) | 47 (40.5) |
| Overall mortality, n/N (%) | 44/116 (37.9) |
| 3 month survival rate, n/N (%) | 83/116 (71.6) |
| 6 month survival rate, n/N (%) | 80/116 (69.0) |
| 12 month survival rate, n/N (%) | 74/116 (63.8) |
| Follow-up duration, mean (s.d.), months | 19.3 (21.6) |
| Characteristics . | Values . |
|---|---|
| Female, n (%) | 65 (56) |
| Age of onset, mean (s.d.), years | 52 (13) |
| Smoker, n (%) | 9 (7.8) |
| Ethnicity, n (%) | |
| Chinese | 112 (97) |
| Indonesian | 2 (2) |
| Malaysian | 1 (1) |
| Subtypes, n (%) | |
| DM | 38 (32.8) |
| CADM | 78 (67.2) |
| PM | 0 (0) |
| ILD, n (%) | 100 (86.2) |
| RP-ILD, n (%) | 47 (40.5) |
| Overall mortality, n/N (%) | 44/116 (37.9) |
| 3 month survival rate, n/N (%) | 83/116 (71.6) |
| 6 month survival rate, n/N (%) | 80/116 (69.0) |
| 12 month survival rate, n/N (%) | 74/116 (63.8) |
| Follow-up duration, mean (s.d.), months | 19.3 (21.6) |
| Characteristics . | Values . |
|---|---|
| Female, n (%) | 65 (56) |
| Age of onset, mean (s.d.), years | 52 (13) |
| Smoker, n (%) | 9 (7.8) |
| Ethnicity, n (%) | |
| Chinese | 112 (97) |
| Indonesian | 2 (2) |
| Malaysian | 1 (1) |
| Subtypes, n (%) | |
| DM | 38 (32.8) |
| CADM | 78 (67.2) |
| PM | 0 (0) |
| ILD, n (%) | 100 (86.2) |
| RP-ILD, n (%) | 47 (40.5) |
| Overall mortality, n/N (%) | 44/116 (37.9) |
| 3 month survival rate, n/N (%) | 83/116 (71.6) |
| 6 month survival rate, n/N (%) | 80/116 (69.0) |
| 12 month survival rate, n/N (%) | 74/116 (63.8) |
| Follow-up duration, mean (s.d.), months | 19.3 (21.6) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
